[Skip to Content]
[Skip to Content Landing]

Acceptance of Different Self-sampling Methods for Semiweekly SARS-CoV-2 Testing in Asymptomatic Children and Childcare Workers at German Day Care CentersA Nonrandomized Controlled Trial

Educational Objective
To identify the key insights or developments described in this article
1 Credit CME
Key Points

Question  What is the acceptance and feasibility of different methods of twice weekly SARS-CoV-2 monitoring in asymptomatic children and childcare workers in day care centers?

Findings  In this nonrandomized controlled trial and feasibility study with 452 children and 139 childcare workers, self-sampled surveillance testing via saliva sampling and/or nasal rapid antigen self-test for SARS-CoV-2 was well accepted and provided a high sense of safety.

Meaning  These findings suggest that self-sampled continuous testing allowing continued day care for children should be established based on age-adjusted SARS-CoV-2 incidence rates.

Abstract

Importance  Closure of day care centers (DCCs) to contain the COVID-19 pandemic has been associated with negative effects on children’s health and well-being.

Objective  To investigate the acceptance of self-sampling methods for continuous SARS-CoV-2 surveillance among asymptomatic children and childcare workers (CCWs) in DCCs.

Design, Setting, and Participants  This nonrandomized pilot study included children and CCWs at 9 DCCs in Wuerzburg, Germany, from May to July 2021.

Interventions  Twice weekly testing for SARS-CoV-2 was conducted by self-sampled mouth-rinsing fluid (saliva sampling [SAL], with subsequent pooled polymerase chain reaction test) plus nasal rapid antigen self-test (RAgT) (group 1), SAL only (group 2), or RAgT only (group 3) in children and CCWs.

Main Outcomes and Measures  Main outcomes were rates for initial acceptance and successful (≥60% of scheduled samples) long-term participation. The probability of SARS-CoV-2 introduction into DCCs was modeled as a function of age-adjusted background incidence and DCC size.

Results  Of 836 eligible children, 452 (54.1%; 95% CI, 50.7%-57.4%) participated (median [IQR] age: 4 [3-5] years; 213 [47.1%] girls), including 215 (47.6%) in group 1, 172 (38.1%) in group 2, and 65 (14.4%) in group 3. Of 190 CCWs, 139 (73.2%; 95% CI, 66.4%-79.0%) participated (median [IQR] age: 30 [25-46] years; 128 [92.1%] women), including 96 (69.1%) in group 1, 29 (20.9%) in group 2, and 14 (10.1%) in group 3. Overall, SARS-CoV-2 PCR tests on 5306 SAL samples and 2896 RAgTs were performed in children, with 1 asymptomatic child detected by PCR from SAL. Successful long-term participation was highest in group 2 (SAL only; children: 111 of 172 [64.5%]; CCWs: 18 of 29 [62.1%]). Weekly participation rates in children ranged from 54.0% to 83.8% for SAL and from 44.6% to 61.4% for RAgT. Participation rates decreased during the study course (P < .001). The probability of SARS-CoV-2 introduction into a DCC with 50 children was estimated to reach at most 5% for an age-adjusted SARS-CoV-2 incidence below 143.

Conclusions and Relevance  Self-sampling for continuous SARS-CoV-2 testing was well accepted, with SAL being the preferred method. Given the high number of negative tests, thresholds for initiating continuous testing should be established based on age-adjusted SARS-CoV-2 incidence rates.

Trial Registration  German Registry for Clinical Trials Identifier: DRKS00025546

Sign in to take quiz and track your certificates

Buy This Activity

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.

Article Information

Accepted for Publication: July 27, 2022.

Published: September 15, 2022. doi:10.1001/jamanetworkopen.2022.31798

Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2022 Engels G et al. JAMA Network Open.

Corresponding Author: Johannes Liese, MD, MSc, Department of Pediatrics, University Children’s Hospital, Josef-Schneider-Str. 2 / D31, D-97080 Würzburg, Germany (liese_j@ukw.de).

Author Contributions: Drs Liese and Kurzai had full access to all study data and take responsibility for the integrity of the data and the accuracy of the data analysis. Drs Engels, Forster, Liese, and Kurzai contributed equally to this work.

Concept and design: Engels, Forster, Streng, Rücker, Pietsch, Schmidt, Jans, Dölken, Heuschmann, Härtel, Gágyor, Liese, Kurzai.

Acquisition, analysis, or interpretation of data: Engels, Forster, Streng, Rücker, Rudolph, Pietsch, J. Wallstabe, L. Wallstabe, Krauthausen, Schmidt, Ludwig, Bauer, Gierszewski, Bendig, Timme, Jans, Weißbrich, Romanos, Gágyor, Figge, Liese, Kurzai.

Drafting of the manuscript: Engels, Forster, Streng, Rudolph, Pietsch, J. Wallstabe, Bendig, Timme, Liese, Kurzai.

Critical revision of the manuscript for important intellectual content: Rücker, J. Wallstabe, L. Wallstabe, Krauthausen, Schmidt, Ludwig, Bauer, Gierszewski, Jans, Weißbrich, Romanos, Dölken, Heuschmann, Härtel, Gágyor, Figge, Liese, Kurzai.

Statistical analysis: Rücker, Rudolph, Schmidt, Bauer, Bendig, Timme, Heuschmann, Figge.

Obtained funding: Romanos, Gágyor, Liese, Kurzai.

Administrative, technical, or material support: Pietsch, J. Wallstabe, L. Wallstabe, Krauthausen, Bendig, Weißbrich, Romanos, Dölken, Härtel, Gágyor, Figge, Liese, Kurzai.

Supervision: Engels, Forster, Streng, Romanos, Heuschmann, Härtel, Figge, Liese, Kurzai.

Conflict of Interest Disclosures: Dr Streng reported receiving grants from GlaxoSmithKline, Janssen-Cilag, Pfizer Pharma, Sanofi Pasteur, and MSD paid to the institution outside the submitted work. Dr Weißbrich reported receiving grants from the Federal Ministry for Education and Science grants during the conduct of the study. Dr Romanos reported receiving grants from Bundesministerium für Bildung und Forschung during the conduct of the study. Dr Heuschmann reported receiving grants from German Ministry of Research and Education, the European Union, the German Parkinson Society, University Hospital Würzburg, Robert Koch Institute, German Heart Foundation, Federal Joint Committee within the Innovationfond, German Research Foundation, Bavarian State (Ministry for Science and the Arts), German Cancer Aid, Charité–Universitätsmedizin Berlin (supported by an unrestricted research grant from Bayer), University Göttingen (supported by an unrestricted research grant from Boehringer-Ingelheim), and grants from University Hospital Heidelberg (supported by an unrestricted research grant from Bayer, BMS, Boehringer-Ingelheim, and Daiichi Sankyo) outside the submitted work. Dr Gágyor reported receiving personal fees from Federal Ministry of Education and Research Germany during the conduct of the study. Dr Liese reported receiving grants from GlaxoSmithKline, Janssen-Cilag, Pfizer, MSD, and Sanofi Pasteur outside the submitted work. Dr Kurzai reported receiving grants from Federal Ministry for Education and Research, Free State of Bavaria, Germany COVID research funds, and the Bavarian Ministry of Health via the Bavarian Office for Health and Food Safety and receiving nonfinancial support from the city of Wuerzburg in the form of vehicles to transport equipment and personnel during the conduct of the study and receiving grants from the Federal Ministry for Education and Research and Bavarian Ministry of Health via the Bavarian Office for Science and Arts outside the submitted work and participating in SARS-CoV-2 expert panels of the city and county of Wuerzburg. No other disclosures were reported.

Funding/Support: The study was funded by the Bavarian State Ministry of Health and Care and the Bavarian Health and Food Safety Authority (GP1i-G8000-2021/278-16) (Dr Liese).

Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Group Information: See Supplement 3.

Data Sharing Statement: See Supplement 4.

Additional Contributions: We thank all participating day care centers and their staff for their friendly support, and all parents, children, and childcare workers for their study participation. We thank the following for their support in organizing the study: Annsophie Amman, Leonie Bode, Inga Enders, Thiemo Frank, Greta Habersack, Viktoria Hamway, Timo Spannagel, Fabian Rothbauer (Institute for Hygiene and Microbiology, University of Wuerzburg); Marianna Abert, Tatjana Durnev, Carolin Glatzle, Antonia Hardung, Katharina Karch, Sebastian Kollert, Tanja Mastorakis, Lena Schregelmann, Victoria Sokalski, Eva-Lotta Tanzberger, Denise Yilmaz, Stefan Zimmerling (Department of Pediatrics, University Hospital Wuerzburg); Brigitte Wehner, Maximilian Siegl (Hematological Laboratory, University Hospital Würzburg). Furthermore, we thank Patricia Niekler, MSc, and Karin Seeger, MPH, for their language support.

References
1.
Sorg  A , Hufnagel  M , Doenhardt  M ,  et al.  Risk of hospitalization, severe disease, and mortality due to COVID-19 and PIMS-TS in children with SARS-CoV-2 infection in Germany.   medRxiv. Preprint posted online November 30, 2021. doi:10.1101/2021.11.30.21267048Google Scholar
2.
Wang  L , Berger  NA , Kaelber  DC , Davis  PB , Volkow  ND , Xu  R .  COVID infection severity in children under 5 years old before and after Omicron emergence in the US.   medRxiv. Preprint posted online January 13, 2022. doi:10.1101/2022.01.12.22269179Google Scholar
3.
Walger  P , Heininger  U , Knuf  M ,  et al. Kinder und Jugendliche in der Covid-19-Pandemie: Schulen und Kitas sollen wieder geöffnet werden. Der Schutz von Lehrern, Erziehern, Betreuern und Eltern und die allgemeinen Hygieneregeln stehen dem nicht entgegen. Accessed August 15, 2022. https://dgpi.de/stellungnahme-schulen-und-kitas-sollen-wieder-geoeffnet-werden/
4.
Haag  L , Blankenburg  J , Unrath  M ,  et al.  Prevalence and transmission of severe acute respiratory syndrome coronavirus type 2 in childcare facilities: a longitudinal study.   J Pediatr. 2021;237:136-142. doi:10.1016/j.jpeds.2021.07.054PubMedGoogle ScholarCrossref
5.
Lachassinne  E , de Pontual  L , Caseris  M ,  et al; COVIDOCRECHE collaborators.  SARS-CoV-2 transmission among children and staff in daycare centres during a nationwide lockdown in France: a cross-sectional, multicentre, seroprevalence study.   Lancet Child Adolesc Health. 2021;5(4):256-264. doi:10.1016/S2352-4642(21)00024-9PubMedGoogle ScholarCrossref
6.
Macartney  K , Quinn  HE , Pillsbury  AJ ,  et al; NSW COVID-19 Schools Study Team.  Transmission of SARS-CoV-2 in Australian educational settings: a prospective cohort study.   Lancet Child Adolesc Health. 2020;4(11):807-816. doi:10.1016/S2352-4642(20)30251-0PubMedGoogle ScholarCrossref
7.
Abufhele  A , Bravo  D , Boo  FL , Soto-Ramirez  P . Developmental losses in young children from pre-primary program closures during the COVID-19 pandemic. Inter-American Development Bank. Accessed February 22, 2022. https://publications.iadb.org/publications/english/document/Developmental-Losses-in-Young-Children-from-Pre-Primary-Program-Closures-during-the-COVID-19-Pandemic.pdf
8.
Lee  EK , Parolin  Z . The care burden during COVID-19: a national database of child care closures in the United States. Socius. Published online July 21, 2021. doi:10.1177/23780231211032028
9.
Calvano  C , Engelke  L , Di Bella  J , Kindermann  J , Renneberg  B , Winter  SM .  Families in the COVID-19 pandemic: parental stress, parent mental health and the occurrence of adverse childhood experiences—results of a representative survey in Germany.   Eur Child Adolesc Psychiatry. 2022;31(7):1-13. doi:10.1007/s00787-021-01739-0PubMedGoogle ScholarCrossref
10.
Petts  RJ , Carlson  DL , Pepin  JR .  A gendered pandemic: childcare, homeschooling, and parents’ employment during COVID-19.   Gend Work Organ. 2021;28(S2):515-534. doi:10.1111/gwao.12614Google ScholarCrossref
11.
Lawson  M , Piel  MH , Simon  M .  Child maltreatment during the COVID-19 pandemic: consequences of parental job loss on psychological and physical abuse towards children.   Child Abuse Negl. 2020;110(Pt 2):104709-104709. doi:10.1016/j.chiabu.2020.104709PubMedGoogle ScholarCrossref
12.
Lee  SJ , Ward  KP , Lee  JY , Rodriguez  CM .  Parental social isolation and child maltreatment risk during the COVID-19 pandemic.   J Fam Violence. 2022;37(5):813-824. doi:10.1007/s10896-020-00244-3PubMedGoogle ScholarCrossref
13.
Joachim  A , Dewald  F , Suárez  I ,  et al; B-FAST study group.  Pooled RT-qPCR testing for SARS-CoV-2 surveillance in schools—a cluster randomised trial.   EClinicalMedicine. 2021;39:101082. doi:10.1016/j.eclinm.2021.101082PubMedGoogle ScholarCrossref
14.
Dewald F, Horemheb-Rubio Quintanares G, Steger G, et al. Lolli-Methode als Grundlage einer SARS-CoV-2- Surveillance in Kitas und Schulen. 2021;(32):3–10. doi:10.25646/8823
15.
Hoehl  S , Kreutzer  E , Schenk  B ,  et al.  Longitudinal testing for respiratory and gastrointestinal shedding of SARS-CoV-2 in day care centres in Hesse, Germany.   Nephrol Dial Transplant. 2021;73(9):e3036-e3041. doi:10.1093/cid/ciaa1912PubMedGoogle ScholarCrossref
16.
Forster  J , Streng  A , Rudolph  P ,  et al; Wü-KiTa-CoV Study Group.  Feasibility of SARS-CoV-2 surveillance testing among children and childcare workers at German day care centers: a nonrandomized controlled trial.   JAMA Netw Open. 2022;5(1):e2142057. doi:10.1001/jamanetworkopen.2021.42057PubMedGoogle ScholarCrossref
17.
Doron  S , Ingalls  RR , Beauchamp  A ,  et al.  Weekly SARS-CoV-2 screening of asymptomatic kindergarten to grade 12 students and staff helps inform strategies for safer in-person learning.   Cell Rep Med. 2021;2(11):100452. doi:10.1016/j.xcrm.2021.100452PubMedGoogle ScholarCrossref
18.
Mendoza  RP , Bi  C , Cheng  HT ,  et al.  Implementation of a pooled surveillance testing program for asymptomatic SARS-CoV-2 infections in K-12 schools and universities.   EClinicalMedicine. 2021;38:101028. doi:10.1016/j.eclinm.2021.101028PubMedGoogle ScholarCrossref
19.
Larremore  DB , Wilder  B , Lester  E ,  et al.  Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening.   Sci Adv. 2021;7(1):eabd5393. doi:10.1126/sciadv.abd5393PubMedGoogle ScholarCrossref
20.
Wagenhäuser  I , Knies  K , Rauschenberger  V ,  et al.  Clinical performance evaluation of SARS-CoV-2 rapid antigen testing in point of care usage in comparison to RT-qPCR.   EBioMedicine. 2021;69:103455. doi:10.1016/j.ebiom.2021.103455PubMedGoogle ScholarCrossref
21.
Wilson  EB .  Probable inference, the law of succession, and statistical inference.   J Am Stat Assoc. 1927;22(158):209-212. doi:10.1080/01621459.1927.10502953Google ScholarCrossref
22.
Flanders  WD , Kleinbaum  DG .  Basic models for disease occurrence in epidemiology.   Int J Epidemiol. 1995;24(1):1-7. doi:10.1093/ije/24.1.1PubMedGoogle ScholarCrossref
23.
Loenenbach A, Markus I, Stauke J, et al. Positivenanteile, RNA-Kopien und Anzuechtbarkeit von Proben zum Isolationsende von SARS-CoV-2 VOC B.1.1.7 („Alpha“) positiven Fallpersonen. Epid Bull. 2021;25:14-18. doi:10.25646/8681
24.
Gierszewski  D , Kurotschka  PK , Krauthausen  M ,  et al.  Parents’ and childcare workers’ perspectives towards SARS-CoV-2 test and surveillance protocols in pre-school children day care centers: a qualitative study within the German Wü-KiTa-CoV project.   Front Med (Lausanne). 2022;9:897726. doi:10.3389/fmed.2022.897726PubMedGoogle ScholarCrossref
25.
Seifried JBS, Oh DY, Hauer B, Schaade L, Hamouda O, Mielke M. PCR-Testkapazitäten nutzen für Personengruppen ohne Impfmöglichkeit: Serielles Screening von Kindern in KiTas und Grundschulen mittels Lolli-Pool-PCR-Testungen auf SARS-CoV-2 als Teil eines Multikomponenten-Präventionskonzepts. Epid Bull. 2021;26:3-8. doi:10.25646/8739
Close
Want full access to the AMA Ed Hub?
After you sign up for AMA Membership, make sure you sign in or create a Physician account with the AMA in order to access all learning activities on the AMA Ed Hub
Buy this activity
Close
Want full access to the AMA Ed Hub?
After you sign up for AMA Membership, make sure you sign in or create a Physician account with the AMA in order to access all learning activities on the AMA Ed Hub
Buy this activity
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close

Name Your Search

Save Search
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Close
Close

Lookup An Activity

or

My Saved Searches

You currently have no searches saved.

Close

My Saved Courses

You currently have no courses saved.

Close